hypertension, hyperglycemia, hyperlipidemia, high uric acid, obesity
Conditions
Interventions
MICT group:Each MICT training is conducted 3 times per week for 12 weeks under supervision. The MICT intervention consisted of 2 × 16-minute continuous aerobic training phases at an intensity of 40-70
HIIT group:HIIT will be done thrice a week on a cycle ergometer under supervision at the research facility for 12 weeks. Each HIIT exercise session consisted of two 8-minute training sessions, totalin
Control group:Participants in this group did not undergo the exercise intervention, but continued their normal daily routines and activities.
Sponsors
Shanghai University of Medicine and Health Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects aged 20 years old or more; 2. Participants who meet one of the diagnostic criteria for hypertension, hyperglycemia, hyperlipidemia, hyperuric acid, or obesity; 3. Be willing to participate and have signed an informed consent form; 4. Be in a stable chronic disease state; 5. Have not participate in regular moderate-intensity physical activities (at least 3 times a week, with lasting at least 30 minutes a day).
Exclusion criteria
Exclusion criteria: 1. Unstable angina pectoris, history of cerebrovascular accident, malignant hypertension, myocardial infarction, heart failure, diabetic ketoacidosis, and other critical illnesses within the last six months; 2. Those with other major chronic diseases, such as chronic kidney disease, systemic lupus erythematosus, chronic hepatitis, hypothyroidism, etc. resulting in abnormal weight and blood glucose; 3. Patients with unstable conditions, such as those with resting systolic blood pressure >200 mmHg or diastolic blood pressure >110 mmHg, uncontrolled peripheral vascular disease or recent frequent hypoglycemic events (<=4 mmol/L); 4. Patients with cancer, acute infections, psychiatric disorders, severe motor system abnormalities, etc. are not suitable for those who receive interventions from this program; 5. Other metabolic abnormalities such as acute thyroiditis, hypokalemia, hyperkalemia, or hypovolemia; 6. Patients with infectious diseases within the last month; 7. People with severe osteoporosis who are unable to tolerate exercise, people with chronic heavy drinking habits and those who are unable to maintain a routine during the intervention period; 8. Those who did not accept the management of the program, could not guarantee that they would follow the prescribed exercise regimen during the intervention, and did not sign the informed consent; 9. Participants who are taking part in other trials that may affect the results of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose (FBG);HbA1c;Insulin;Blood pressure;Weight;Height;Waist circumference;Blood lipid;Uric acid; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate;Bone mineral density;Body composition;Maximal oxygen uptake;Grip strength;Walk speed;TUGT;SPPB;Anxiety;Depression;Life quality ;Sleep; | — |
Countries
China
Contacts
Public ContactQi Guo
Shanghai University of Medicine and Health Sciences
Outcome results
None listed